Ligand validation:6G9X

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 6G9X designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G9X_BNG_B_507	44%	32%	0.177	0.905	1.28	1.4	1	4	2	0	100%	1
6G9X_BNG_B_508	38%	32%	0.174	0.874	1.25	1.46	2	5	0	0	100%	1
6G9X_BNG_A_510	33%	34%	0.187	0.866	1.21	1.39	2	3	0	0	100%	1
6G9X_BNG_A_509	29%	40%	0.209	0.866	1.3	1.06	2	2	0	0	100%	1
6G9X_BNG_B_509	19%	35%	0.218	0.815	1.32	1.23	2	2	0	0	100%	1
6G9X_BNG_A_511	5%	36%	0.39	0.812	1.33	1.19	2	2	2	0	100%	1
6HCL_BNG_A_502	9%	42%	0.269	0.764	1.09	1.14	1	3	0	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4DVE_BNG_B_202	81%	66%	0.092	0.945	0.47	0.83	-	1	0	0	100%	0.5
5B0W_BNG_F_304	74%	49%	0.088	0.917	1.25	0.73	3	-	2	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
4MUU_BNG_A_202	70%	41%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.